New Zealand hemp deregulation and 1.0% THC limit: risks?

Draft introduction paragraph

New Zealand hemp deregulation and 1.0% THC limit takes effect with the THC cap raised to 1.0% and routine Ministry of Health licences for hemp cultivation and handling removed. The Misuse of Drugs (Industrial Hemp) Regulations 2006 were revoked by the Industrial Hemp revocation order.

Growers can scale production, adopt higher yielding cultivars for fibre and seed, and pursue local value added processing, while investors gain clearer legal certainty and reduced licensing costs. Exporters and processors will still need robust THC testing and segregation strategies, and growers must follow MPI notification requirements before planting.

This article explains the rule changes, practical compliance steps including MPI guidance and THC testing, and trade implications for producers and exporters.

New Zealand hemp deregulation and 1.0% THC limit

The 2006 hemp licensing regime was revoked on 28 May 2026, the THC cap raised to 1.0 percent and licences replaced by a notification to Police and MPI (revocation order).

Growers can scale cultivation and pursue fibre seed and value added processing, while exporters must manage testing and traceability (MPI guidance).

See Background for details.

Background of New Zealand hemp deregulation and 1.0% THC limit

2006 rules

New Zealand introduced strict controls under the Misuse of Drugs (Industrial Hemp) Regulations 2006, which limited cultivation to approved cultivars and set a 0.35 percent THC cap. The regime required Ministry of Health licences and narrow product definitions that constrained commercial development.

What changed in 2026

The 2006 regulations were revoked on 28 May 2026 and replaced with a looser framework; the revocation is recorded in the official order here. The reform raised the THC threshold to 1.0 percent and removed routine licence requirements to reduce bureaucratic barriers.

Notification process

Growers must now provide an MPI notification and inform New Zealand Police before planting, creating an early-notice oversight mechanism. Ministry for Primary Industries guidance explains the notification steps, product definitions and practical compliance measures here.

Remaining restrictions

Leaf, flower and root materials remain restricted and need specific authorisation to be used or sold. Transfers of hemp biomass into medicinal channels are subject to permit and oversight by the Medicinal Cannabis Agency, and animal feed uses remain regulated under the ACVM Act.

Comparison of global hemp THC limits including New Zealand

For context, the table below compares legal THC limits and the primary regulators. Therefore, you can see how New Zealand’s 1.0% limit relates to major markets and trading partners.

Notes: limits are expressed on a dry-weight basis and measurement methods vary between jurisdictions. As a result, New Zealand’s 1.0% threshold is higher than North American and EU standards, which may affect export compliance and cultivar selection.

1.0% THC impact on industry

Raising the THC cap to 1.0 percent reshapes incentives for growers, processors and exporters.

Benefits

• Increased cultivar flexibility allows growers to prioritise fibre and seed yield, which supports value added manufacturing and processing.
  • Adopt on farm testing and traceability to document batch quality for buyers and support export compliance.
• Reduced licensing burden cuts time and cost for entry, which encourages new investment and farm level scaling.
  • Notify Police and MPI before planting and retain records per MPI hemp guidance for growers and businesses here.
• Clearer legal status helps reduce stigma, which may attract commercial finance and joint ventures.
  • Share third party certificates of analysis with partners and embed testing and traceability into supply chains to boost buyer confidence.

Challenges

• Export compliance risk rises because many markets use a 0.3 percent THC limit, so exporters need robust testing and segregation strategies.
  • Segregate harvests and test batches to a 0.3 percent standard for target markets and obtain accredited certificates of analysis to reduce border rejection risk.
• Product definitions still restrict leaf flower and root materials, limiting some high margin markets.
  • Seek Medicinal Cannabis Agency permits where relevant or pivot product lines toward seed and fibre processing.
• Animal feed remains regulated under the ACVM Act, delaying feed market entry until authorisation is secured.
  • Review the MPI ACVM alert on agricultural compounds and prepare registration dossiers early here.

Conclusion

New Zealand hemp deregulation and 1.0% THC limit is a watershed moment for the sector. Because the cap rose to 1.0% and routine licences were removed, growers gain cultivar flexibility and clearer commercial pathways. However, product definitions and animal feed rules still restrict some uses and require careful legal compliance.

As a result, domestic processing, fibre and seed markets should expand, which creates jobs and investment opportunities. Meanwhile, exporters face higher compliance demands because many trading partners keep lower THC thresholds. Therefore, businesses must invest in testing, segregation and traceability to reduce trade risk.

The reform opens real opportunity, but success will depend on strategy, testing standards and market alignment. For practical regulatory updates and guidance, consult policy and compliance guidance at My CBD Advisor. Looking ahead, MPI and cabinet reviews will determine trade access and the industry’s growth trajectory, so stakeholders should stay engaged and prepared to adapt.

Frequently Asked Questions (FAQs)

Related on CBD Advisor

• Moldova hemp framework for seeds and fiber value chains? 🚀
• What reforms in Industrial hemp policy and regulation needed
• What Does the Lawful Hemp Protection Act (LHPA) Change